Synthetic Genomics, Inc.

Synthetic Genomics, Inc.

Synthetic Genomics, Inc.

Overview
Date Founded

2005

Headquarters

11149 North Torrey Pines Road,La Jolla, CA 92037

Type of Company

Private

Employees (Worldwide)

501 - 1,000

Industries

Other Business & Consulting Services
Hospitals & Patient Services
Medical Support Services
Holding Companies
Biotechnology

Company Description

Synthetic Genomics, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Contact Data
Trying to get in touch with decision makers at Synthetic Genomics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

General Counsel, Corporate Secretary

Chief Business Officer

Benefit Plan Administrator

Chief Sales, Marketing Officer & Senior Vice President-Genovia

Vice President, BioInformatics & Information Technology

Vice President, DNA Technology

Vice President, Engineering & Instrumentation

Vice President, Intellectual Property

Board of Directors

Deputy Chairman & Chief Executive at Genting Malaysia Bhd.

Co-Founder at Synthetic Genomics, Inc.

DFJ Growth, Managing Director at Unity Technologies SF

Former Venture Partner at Tullis Health Investors, Inc.

Chief Executive Officer at Synthetic Genomics, Inc.

Chief Financial Officer at C4 Therapeutics, Inc.

Co-Founder at Synthetic Genomics, Inc.

Former President at Novartis Venture Fund

Member, Board of Directors at Synthetic Genomics, Inc.

Chairman & Chief Executive Officer at Plenus SA De CV

Paths to Synthetic Genomics, Inc.
Potential Connections via
Relationship Science
You
Synthetic Genomics, Inc.
Recent Transactions
Details Hidden

Synthetic Genomics, Inc. raised money in a private placement transaction

Details Hidden

Synthetic Genomics, Inc. raised money in a private placement transaction

Advisors & Consultants
Scientific Advisor

Founder at J. Craig Venter Institute

Legal Advisor

Of Counsel at Gibson, Dunn & Crutcher LLP

Non-Profit Donations & Grants
Investors
Details Hidden

BP Ventures invest in private, high growth, game-changing technology companies across the entire energy spectrum. The firm have focus on five key areas bio & low carbon products, carbon management, power & storage, advanced mobility and digital transformation.

Details Hidden

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Details Hidden

Genting Bhd. is an investment holding and management company, which engages in the leisure and hospitality, gaming, and entertainment businesses. It operates through the following segments: Leisure and Hospitality, Plantation, Power, Property, Oil and Gas, and Investments and Others. The Leisure and Hospitality segment includes gaming, hotels, food and beverages, theme parks, retail, entertainment and attractions, tours and travel related services, development and operation of integrated resorts, and other support services. The Plantation segment involves in the oil palm plantations, palm oil milling, and related activities. The Power segment generates and supplies electric power. The Property segment focuses on the property development activities and property investment. The Oil and Gas segment consists of exploration, development, and production activities. The Investments and Others segment refers to the investment and interest income from financial assets. The company was founded by Goh Tong Lim in 1965 and is headquartered in Kuala Lumpur, Malaysia.

Suppliers
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals | San Diego, CA

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Synthetic Genomics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Synthetic Genomics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Synthetic Genomics, Inc..